Strong demand for single-use technologies has returned double-digit growth for Pall, contributing to a “return to normality” for Danaher Corporation’s life sciences business. For its second quarter 2018, Danaher Corporation reported total revenues across its life sciences businesses of US$1.6 billion (€1.4 billion), up 16% over the same period last year. The multinational attributed much of the growth to Pall Corporation – the filtration, separations and purification firm it acquired for $13.6 billion in 2015 – though CEO Tom Joyce…